top of page

One vulnerability, read two ways.

Real findings from our own research, disclosed with the vendors and published as CVEs. Read each one as an exploit interfaces, chains and bench evidence or as a business risk: what it costs, who it lands on and what to fund first.

Findings our team reported through coordinated disclosure. Each case carries its CVE reference and links to the published advisory.

Choose your lens

Two pills. One finding. Which layer do you want to see?

Every case below can be read as an exploit or as a business risk. Take the pill that matches the room you are standing in you can switch at any time.

FOR ENGINEERS

Red Pill

Show me how it breaks

Follow the attack itself: the exposed interface, the chain we ran on the bench, and the output that proves it.

  • Attack surface

  • Reproduction chain

  • Bench evidence

  • Remediation detail

FOR LEADERSHIP

Blue Pill

Show me what it costs

Follow the consequence: who it lands on, what it puts at risk, and where the next dollar should go.

  • Exposure in plain terms

  • Business impact

  • Risk in one line

  • What to fund first

Start with a 30-min scoping call

We will discuss your environment, explain the most relevant testing approach, and confirm whether Exploit Security is the right fit.

bottom of page